Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice

Journal of Clinical Investigation

Volumn 116, Issue 3, 2006, Pages 808-816

  Belcher, John D ^a   Mahaseth, Hemachandra ^a   Welch, Thomas E ^a   Otterbein, Leo E ^b   Hebbel, Robert P ^a   Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; CELL ADHESION MOLECULE; HAPTOGLOBIN; HEME; HEME OXYGENASE; HEME OXYGENASE 1; HEMIN; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROTOPORPHYRIN TIN; RECOMBINANT ENZYME; VASCULAR CELL ADHESION MOLECULE 1;

ADENOVIRUS; ADENOVIRUS VECTOR; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD VESSEL OCCLUSION; CELL INTERACTION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME INHIBITION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HYPOXIA; IN VIVO STUDY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SUBCUTANEOUS TISSUE; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULITIS; VIRAL GENE THERAPY;

ANEMIA, SICKLE CELL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEME OXYGENASE-1; HEMIN; INFLAMMATION MEDIATORS; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROTOPORPHYRINS; UP-REGULATION; VASOCONSTRICTION;

EID: 33644649611     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI26857     Document Type: Article

References (86)

1. Nagel, R.L., and Fabry, M.E. 2001. The panoply of animal models for sickle cell anaemia. Br. J. Haematol. 112:19-25.
2. Belcher, J.D., et al. 2005. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am. J. Physiol. Heart Circ. Physiol. 288:H2715-H2725.
3. Mahaseth, H., et al. 2005. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J. Lab. Clin. Med. 145:204-211.
4. Kaul, D.K., and Hebbel, R.P. 2000. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106:411-420.
5. Kaul, D.K., et al. 2004. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am. J. Physiol. Heart Circ. Physiol. 287:H293-H301.
6. Embury, S.H., et al. 2004. The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood. 104:3378-3385.
7. Turhan, A., Weiss, L.A., Mohandas, N., Coller, B.S., and Frenette, P.S. 2002. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. U. S. A. 99:3047-3051.
8. Setty, B.N., and Stuart, M.J. 1996. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood. 88:2311-2320.
9. Lavrovsky, Y., Chatterjee, B., Clark, R.A., and Roy, A.K. 2000. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol. 35:521-532.
10. Park, H.S., et al. 2004. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 173:3589-3593.
11. Victor, V.M., Rocha, M., and De la Fuente, M. 2003. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic. Res. 37:919-929.
12. Chen, X.L., Zhang, Q., Zhao, R., and Medford, R.M. 2004. Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 286:H1001-H1007.
13. Balla, J., et al. 2003. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol. Dial. Transplant. 18:v8-v12.
14. Balla, G., Vercellotti, G., Eaton, J.W., and Jacob, H.S. 1990. Heme uptake by endothelium synergizes polymorphonuclear granulocyte-mediated damage. Trans. Assoc. Am. Physicians. 103:174-179.
15. Balla, G., Vercellotti, G.M., Eaton, J.W., and Jacob, H.S. 1990. Iron loading of endothelial cells augments oxidant damage. J. Lab. Clin. Med. 116:546-554.
16. Bunn, H.F., and Jandl, J.H. 1968. Exchange of heme among hemoglobins and between hemoglobin and albumin. J. Biol. Chem. 243:465-475.
17. Hebbel, R.P., Morgan, W.T., Eaton, J.W., and Hedlund, B.E. 1988. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. U. S. A. 85:237-241.
18. Balla, G., et al. 1992. Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267:18148-18153.
19. Rublevskaya, I., and Maines, M.D. 1994. Interaction of Fe-protoporphyrin IX and heme analogues with purified recombinant heme oxygenase-2, the constitutive isozyme of the brain and testes. J. Biol. Chem. 269:26390-26395.
20. McCoubrey, W.K., Jr., Huang, T.J., and Maines, M.D. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247:725-732.
21. Maines, M.D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517-554.
22. Otterbein, L.E., Soares, M.P., Yamashita, K., and Bach, F.H. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449-455.
23. Harrison, P.M., and Arosio, P. 1996. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta. 1275:161-203.
24. Wagener, F.A., et al. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55:551-571.
25. Yachie, A., et al. 1999. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:129-135.
26. Wagener, F.A., et al. 2001. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood. 98:1802-1811.
27. Kawashima, A., Oda, Y., Yachie, A., Koizumi, S., and Nakanishi, I. 2002. Heme oxygenase-1 deficiency: the first autopsy case. Hum. Pathol. 33:125-130.
28. Soares, M.P., et al. 2004. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 172:3553-3563.
29. Wagener, F.A., et al. 1999. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther. 291:416-423.
30. Hayashi, S., et al. 1999. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85:663-671.
31. Vachharajani, T.J., Work, J., Issekutz, A.C., and Granger, D.N. 2000. Heme oxygenase modulates selectin expression in different regional vascular beds. Am. J. Physiol. Heart Circ. Physiol. 278:H1613-H1617.
32. Rucker, M., et al. 2001. Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery. 129:292-301.
33. Wang, X., et al. 2004. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. U. S. A. 101:11477-11482.
34. Reiter, C.D., et al. 2002. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8:1383-1389.
35. Berry, E.A., and Trumpower, B.L. 1987. Simultaneous determination of hemes a, b, and c from pyridine hemochrome spectra. Anal. Biochem. 161:1-15.
36. Balla, J., et al. 1995. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am. J. Physiol. 268:L321-L327.
37. Belcher, J.D., et al. 2003. Transgenic sickle mice have vascular inflammation. Blood. 101:3953-3959.
38. Otterbein, L.E., et al. 1999. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103:1047-1054.
39. Nath, K.A., et al. 2001. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am. J. Pathol. 158:893-903.
40. Jison, M.L., et al. 2004. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood. 104:270-280.
41. Nagel, R.L. 1994. Lessons from transgenic mouse lines expressing sickle hemoglobin. Proc. Soc. Exp. Biol. Med. 205:274-281.
42. Osarogiagbon, U.R., et al. 2000. Reperfusion injury pathophysiology in sickle transgenic mice. Blood. 96:314-320.
43. Kalambur, V.S., et al. 2004. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am. J. Hematol. 77:117-125.
44. Embury, S.H., Mohandas, N., Paszty, C., Cooper, P., and Cheung, A.T. 1999. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J. Clin. Invest. 103:915-920.
45. Kaul, D.K., Fabry, M.E., Costantini, F., Rubin, E.M., and Nagel, R.L. 1995. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J. Clin. Invest. 96:2845-2853.
46. Fabry, M.E., et al. 1995. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood. 86:2419-2428.
47. Paszty, C., et al. 1997. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 278:876-878.
48. Manci, E.A., et al. 2005. Pathology of "Berkeley" sickle cell mice: similarities and differences with human sickle cell disease. Blood. doi:10.1182/blood-2005-07-2839.
49. Hata, K., et al. 2003. Induction of heme oxygenase-1 and dilation of hepatic sinusoids by an administration of pyrrolidine dithiocarbamate in rat livers. J. Surg. Res. 115:310-317.
50. Sarady, J.K., et al. 2004. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J. 18:854-856.
51. Sawle, P., et al. 2005. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 145:800-810.
52. Marshall, H.E., Hess, D.T., and Stamler, J.S. 2004. S-nitrosylation: physiological regulation of NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 101:8841-8842.
53. Ryter, S.W., Otterbein, L.E., Morse, D., and Choi, A.M. 2002. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234-235:249-263.
54. Ohta, K., and Yachie, A. 2004. Development of vascular biology over the past 10 years: heme oxygenase-1 in cardiovascular homeostasis. J. Endovasc. Ther. 11(Suppl. 2):II140-II150.
55. Gladwin, M.T., and Schechter, A.N. 2001. Nitric oxide therapy in sickle cell disease. Semin. Hematol. 38:333-342.
56. Reiter, C.D., and Gladwin, M.T. 2003. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 10:99-107.
57. Wolin, M.S., Davidson, C.A., Kaminski, P.M., Fayngersh, R.P., and Mohazzab, H.K. 1998. Oxidant-nitric oxide signalling mechanisms in vascular tissue. Biochemistry Mosc. 63:810-816.
58. Beckman, J.S., and Crow, J.P. 1993. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:330-334.
59. Beckman, J.S., and Koppenol, W.H. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424-C1437.
60. Beutler, E. 1975. The effect of carbon monoxide on red cell life span in sickle cell disease. Blood. 46:253-259.
61. Stocker, R., McDonagh, A.F., Glazer, A.N., and Ames, B.N. 1990. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 186:301-309.
62. Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., and Ames, B.N. 1987. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1043-1046.
63. Dailly, E., Urien, S., Barre, J., Reinert, P., and Tillement, J.P. 1998. Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell disease. Biochem. Biophys. Res. Commun. 248:303-306.
64. Kaur, H., et al. 2003. Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett. 543:113-119.
65. Mancuso, C., Bonsignore, A., Di Stasio, E., Mordente, A., and Motterlini, R. 2003. Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem. Pharmacol. 66:2355-2363.
66. Miralem, T., Hu, Z., Torno, M.D., Lelli, K.M., and Maines, M.D. 2005. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J. Biol. Chem. 280:17084-17092.
67. Theil, E.C. 2003. Ferritin: at the crossroads of iron and oxygen metabolism. J. Nutr. 133:1549S-1553S.
68. Arosio, P., and Levi, S. 2002. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33:457-463.
69. Cozzi, A., et al. 2000. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J. Biol. Chem. 275:25122-25129.
70. Epsztejn, S., et al. 1999. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 94:3593-3603.
71. Berberat, P.O., et al. 2003. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 17:1724-1726.
72. Erario, M.A., Gonzales, S., Noriega, G.O., and Tomaro, M.L. 2002. Bilirubin and ferritin as protectors against hemin-induced oxidative stress in rat liver. Cell. Mol. Biol. (Noisy-le-grand). 48:877-884.
73. Gonzales, S., Erario, M.A., and Tomaro, M.L. 2002. Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev. Neurosci. 24:161-168.
74. Foidart, M., Liem, H.H., Adornato, B.T., Engel, W.K., and Muller-Eberhard, U. 1983. Hemopexin metabolism in patients with altered serum levels. J. Lab. Clin. Med. 102:838-846.
75. Wochner, R.D., Spilberg, I., Iio, A., Liem, H.H., and Muller-Eberhard, U. 1974. Hemopexin metabolism in sickle-cell disease, porphyrias and control subjects: effects of heme injection. N. Engl. J. Med. 290:822-826.
76. Fertakis, A., Panitsas, G., and Angelopoulos, B. 1973. Serum haemopexin concentration in patients with various haemoglobinopathies. Effect of splenectomy. Acta Haematol. 50:149-153.
77. Muller-Eberhard, U., Javid, J., Liem, H.H., Hanstein, A., and Hanna, M. 1968. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 32:811-815.
78. Kato, G.J., et al. 2005. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood. doi:10.1182/blood-2005-06-2373.
79. Nolan, V.G., Wyszynski, D.F., Farrer, L.A., and Steinberg, M.H. 2005. Hemolysis-associated priapism in sickle cell disease. Blood. 106:3264-3267.
80. Lee, T.S., Chang, C.C., Zhu, Y., and Shyy, J.Y. 2004. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 110:1296-1302.
81. Grosser, N., et al. 2004. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic. Biol. Med. 37:2064-2071.
82. Exner, M., Minar, E., Wagner, O., and Schillinger, M. 2004. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37:1097-1104.
83. Exner, M., et al. 2001. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J. Endovasc. Ther. 8:433-440.
84. Martinek, R.G. 1966. Improved micro-method for determination of serum bilirubin. Clin. Chim. Acta. 13:161-170.
85. Baatz, H., Steinbauer, M., Harris, A.G., and Krombach, F. 1995. Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int. J. Microcirc. Clin. Exp. 15:85-91.
86. Mahoney, J.J., Vreman, H.J., Stevenson, D.K., and Van Kessel, A.L. 1993. Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin. Chem. 39:1693-1700.